SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-18-003734
Filing Date
2018-03-22
Accepted
2018-03-22 06:06:46
Documents
5
Period of Report
2018-03-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 33238
2 ex1-1.htm EX-1.1 84234
3 ex5-1.htm EX-5.1 10709
4 ex1-1_001.jpg GRAPHIC 11689
5 ex10-1.htm EX-10.1 191953
  Complete submission text file 0001493152-18-003734.txt   337499
Mailing Address 860 N. ORANGE AVENUE SUITE B ORLANDO FL 32801
Business Address 860 N. ORANGE AVENUE SUITE B ORLANDO FL 32801 407-271-8516
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-27072 | Film No.: 18705642
SIC: 2836 Biological Products, (No Diagnostic Substances)